FDA Inspection 1117609 — Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc.

Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. — FEI 2577603

The FDA completed an inspection of Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. on Feb 11, 2020 in Newark, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 11, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, DE (United States)

Citations

IDCFRDescription
923621 CFR 630.40(b)(1)Deferred or not eligible
923921 CFR 630.40(b)(4)Follow up and counseling

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.